thefederalregister.com

Daily Rules, Proposed Rules, and Notices of the Federal Government

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Chapter I

[Docket No. FDA-2012-N-0780]

Regulatory New Drug Review: Solutions for Study Data Exchange Standards; Notice of Meeting; Request for Comments; Correction

AGENCY: Food and Drug Administration, HHS.
ACTION: Announcement of meeting; request for comments; correction.
SUMMARY: The Food and Drug Administration (FDA) is correcting a document that appeared in theFederal Registerof August 14, 2012 (77 FR 48491). The document announced a meeting entitled "Regulatory New Drug Review: Solutions for Study Data Exchange Standards." The document was published with an incorrect email address. This document corrects that error.
FOR FURTHER INFORMATION CONTACT: Ron Fitzmartin, Office of Planning & Informatics, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 1160, Silver Spring, MD 20993-0002, 301-796-5333, FAX: 301-847-8443, email:CDERDataStandards@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:

In FR Doc. 2012-19748, appearing on page 48491 in theFederal Registerof August 14, 2012, the following corrections are made:

1. On page 48491, in the first column, in theFOR FURTHER INFORMATION CONTACTsection, the email address “CDERDataStandards@hhs.fda.gov” is corrected to read “CDERDataStandards@fda.hhs.gov.”

2. On page 48491, in the second column, in theSUPPLEMENTARY INFORMATIONsection, under “Registration,” the email address “CDERDataStandards@hhs.fda.gov” is corrected to read “CDERDataStandards@fda.hhs.gov.”

Dated: September 11, 2012. Leslie Kux, Assistant Commissioner for Policy.